Subcutaneous injections of dextrose in musculoskeletal pain, a potential therapeutic intervention: scoping review.

IF 1.4 Q4 CLINICAL NEUROLOGY
Pain management Pub Date : 2024-12-01 Epub Date: 2024-12-23 DOI:10.1080/17581869.2024.2442898
Pedro Iván Arias-Vázquez, Russell Arcila-Novelo, Mauro Nicolás Guzzardo, Duilio Román Guzzardo, Miguel Ángel Nazul Ake-Montiel, André Sulub-Herrera
{"title":"Subcutaneous injections of dextrose in musculoskeletal pain, a potential therapeutic intervention: scoping review.","authors":"Pedro Iván Arias-Vázquez, Russell Arcila-Novelo, Mauro Nicolás Guzzardo, Duilio Román Guzzardo, Miguel Ángel Nazul Ake-Montiel, André Sulub-Herrera","doi":"10.1080/17581869.2024.2442898","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The aims of this review were to identify and to analyze the clinical studies that used subcutaneous injections of dextrose for treating musculoskeletal pain, in order to establish an overview.</p><p><strong>Methods: </strong>A systematic search was carried out in scientific databases including Web of Science, Cochrane Central Register of Controlled Trials, PUBMED and other sources, up until March 2024. We included clinical studies that used subcutaneous injections of dextrose in the treatment of individuals with musculoskeletal pain associated with tendinopathies, enthesopathy, osteoarthritis, ligament sprains, muscle strains or bursitis of various locations.</p><p><strong>Results: </strong>Twenty studies that met the criteria were included in this review; of those, 13 were randomized clinical trials, one non-randomized comparative study and six were case series studies, comprising a total of 1226 patients. In all included studies, efficacy in pain reduction was reported in the groups treated with dextrose when comparing evaluations at baseline, short term and medium term.</p><p><strong>Conclusions: </strong>Subcutaneous injections of dextrose could be a beneficial treatment for reducing musculoskeletal pain; however, factors such as the high heterogeneity in the treatment schemes, uncertainty in the mechanisms of action and the level of evidence found, indicate that this technique is still under development.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":" ","pages":"653-663"},"PeriodicalIF":1.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703374/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17581869.2024.2442898","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/23 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The aims of this review were to identify and to analyze the clinical studies that used subcutaneous injections of dextrose for treating musculoskeletal pain, in order to establish an overview.

Methods: A systematic search was carried out in scientific databases including Web of Science, Cochrane Central Register of Controlled Trials, PUBMED and other sources, up until March 2024. We included clinical studies that used subcutaneous injections of dextrose in the treatment of individuals with musculoskeletal pain associated with tendinopathies, enthesopathy, osteoarthritis, ligament sprains, muscle strains or bursitis of various locations.

Results: Twenty studies that met the criteria were included in this review; of those, 13 were randomized clinical trials, one non-randomized comparative study and six were case series studies, comprising a total of 1226 patients. In all included studies, efficacy in pain reduction was reported in the groups treated with dextrose when comparing evaluations at baseline, short term and medium term.

Conclusions: Subcutaneous injections of dextrose could be a beneficial treatment for reducing musculoskeletal pain; however, factors such as the high heterogeneity in the treatment schemes, uncertainty in the mechanisms of action and the level of evidence found, indicate that this technique is still under development.

皮下注射葡萄糖治疗肌肉骨骼疼痛,一种潜在的治疗干预:范围综述。
背景:本综述的目的是识别和分析使用皮下注射葡萄糖治疗肌肉骨骼疼痛的临床研究,以建立一个概述。方法:系统检索截至2024年3月的科学数据库,包括Web of Science、Cochrane Central Register of Controlled Trials、PUBMED等。我们纳入了使用葡萄糖皮下注射治疗与肌腱病、骨髓炎、骨关节炎、韧带扭伤、肌肉拉伤或不同部位滑囊炎相关的肌肉骨骼疼痛的临床研究。结果:本综述纳入了20项符合标准的研究;其中13项为随机临床试验,1项为非随机比较研究,6项为病例系列研究,共纳入1226例患者。在所有纳入的研究中,在比较基线、短期和中期评估时,用葡萄糖治疗的组报告了疼痛减轻的疗效。结论:皮下注射葡萄糖可有效减轻骨骼肌疼痛;然而,诸如治疗方案的高度异质性、作用机制的不确定性以及所发现的证据水平等因素表明,该技术仍处于发展阶段。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pain management
Pain management CLINICAL NEUROLOGY-
CiteScore
2.90
自引率
5.90%
发文量
62
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信